US 12,168,018 B1
Pharmacologically active liposomal composition comprising quercetin and zinc
Ganna Gryhorieva, Kyiv (UA); Nataliia Konakhovych, Vasylkiv (UA); Yurii Krasnopolskyi, Kharkov (UA); Oleksandr Pylypenko, Kyiv (UA); Vitalii Prokhorov, Kharkov (UA); Zinaida Suvorova, Sofiivska Borshchahivka (UA); and Oleg Yadlovski, Kyiv (UA)
Assigned to CONSORTIUM “UKRINDUSTRY”, Kyiv (UA); and STATE INSTITUTION INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY OF NATIONAL ACADEMY MEDICAL SCIENCES OF UKRAINE, Kyiv (UA)
Filed by CONSORTIUM “UKRINDUSTRY”, Kyiv (UA); and STATE INSTITUTION INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY OF NATIONAL ACADEMY MEDICAL SCIENCES OF UKRAINE, Kyiv (UA)
Filed on Dec. 28, 2023, as Appl. No. 18/399,141.
Claims priority of application No. 2023 04351 (UA), filed on Sep. 14, 2023.
Int. Cl. A61K 31/685 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 9/127 (2006.01); A61K 31/353 (2006.01); A61K 31/7016 (2006.01); A61K 33/30 (2006.01); A61P 11/08 (2006.01)
CPC A61K 31/685 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 9/107 (2013.01); A61K 9/127 (2013.01); A61K 31/353 (2013.01); A61K 31/7016 (2013.01); A61K 33/30 (2013.01); A61P 11/08 (2018.01)] 4 Claims
 
1. A pharmacologically active liposomal composition for treating an acute respiratory distress syndrome, the composition comprising phosphatidyl choline, quercetin, lactose, and zinc chloride at a ratio of content of phosphatidyl choline:quercetin:zinc ion in liposomes being from 1:0.027:0.002 to 1:0.027:0.023 wherein the composition is a lyophilized powder having a ratio of components (wt. %) as follows:
quercetin—1,
phosphatidyl choline—36.7,
zinc ion—0.11-0.43,
lactose—54.51,
remainder—water, chloride ion.